Ann Arbor Stage II Non-Hodgkin Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0113043 (Ann Arbor Stage II Non-Hodgkin Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs